<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34375505</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1538-7836</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>10</Issue><PubDate><Year>2021</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of thrombosis and haemostasis : JTH</Title><ISOAbbreviation>J Thromb Haemost</ISOAbbreviation></Journal><ArticleTitle>Persistent endotheliopathy in the pathogenesis of long COVID syndrome.</ArticleTitle><Pagination><StartPage>2546</StartPage><EndPage>2553</EndPage><MedlinePgn>2546-2553</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jth.15490</ELocationID><Abstract><AbstractText Label="BACKGROUND">Persistent symptoms including breathlessness, fatigue, and decreased exercise tolerance have been reported in patients after acute SARS-CoV-2 infection. The biological mechanisms underlying this "long COVID" syndrome remain unknown. However, autopsy studies have highlighted the key roles played by pulmonary endotheliopathy and microvascular immunothrombosis in acute COVID-19.</AbstractText><AbstractText Label="OBJECTIVES">To assess whether endothelial cell activation may be sustained in convalescent COVID-19 patients and contribute to long COVID pathogenesis.</AbstractText><AbstractText Label="PATIENTS AND METHODS">Fifty patients were reviewed at a median of 68&#xa0;days following SARS-CoV-2 infection. In addition to clinical workup, acute phase markers, endothelial cell (EC) activation and NETosis parameters and thrombin generation were assessed.</AbstractText><AbstractText Label="RESULTS">Thrombin generation assays revealed significantly shorter lag times (p&#xa0;&lt;&#xa0;.0001, 95% CI -2.57 to -1.02 min), increased endogenous thrombin potential (p&#xa0;=&#xa0;.04, 95% CI 15-416&#xa0;nM/min), and peak thrombin (p&#xa0;&lt;&#xa0;.0001, 95% CI 39-93&#xa0;nM) in convalescent COVID-19 patients. These prothrombotic changes were independent of ongoing acute phase response or active NETosis. Importantly, EC biomarkers including von Willebrand factor antigen (VWF:Ag), VWF propeptide (VWFpp), and factor VIII were significantly elevated in convalescent COVID-19 compared with controls (p&#xa0;=&#xa0;.004, 95% CI 0.09-0.57&#xa0;IU/ml; p&#xa0;=&#xa0;.009, 95% CI 0.06-0.5&#xa0;IU/ml; p&#xa0;=&#xa0;.04, 95% CI 0.03-0.44&#xa0;IU/ml, respectively). In addition, plasma soluble thrombomodulin levels were significantly elevated in convalescent COVID-19 (p&#xa0;=&#xa0;.02, 95% CI 0.01-2.7&#xa0;ng/ml). Sustained endotheliopathy was more frequent in older, comorbid patients, and those requiring hospitalization. Finally, both plasma VWF:Ag and VWFpp levels correlated inversely with 6-min walk tests.</AbstractText><AbstractText Label="CONCLUSIONS">Collectively, our findings demonstrate that sustained endotheliopathy is common in convalescent COVID-19 and raise the intriguing possibility that this may contribute to long COVID pathogenesis.</AbstractText><CopyrightInformation>&#xa9; 2021 The Authors. Journal of Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fogarty</LastName><ForeName>Helen</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-8161-7931</Identifier><AffiliationInfo><Affiliation>Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Townsend</LastName><ForeName>Liam</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, St James's Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, School of Medicine, Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morrin</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmad</LastName><ForeName>Azaz</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Comerford</LastName><ForeName>Claire</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karampini</LastName><ForeName>Ellie</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-4082-076X</Identifier><AffiliationInfo><Affiliation>Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Englert</LastName><ForeName>Hanna</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center Hamburg- Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Byrne</LastName><ForeName>Mary</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>National Coagulation Centre, St James's Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bergin</LastName><ForeName>Colm</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, St James's Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, School of Medicine, Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Sullivan</LastName><ForeName>Jamie M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin-Loeches</LastName><ForeName>Ignacio</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, St James's Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nadarajan</LastName><ForeName>Parthiban</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, St James's Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bannan</LastName><ForeName>Ciaran</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, St James's Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mallon</LastName><ForeName>Patrick W</ForeName><Initials>PW</Initials><AffiliationInfo><Affiliation>Centre for Experimental Pathogen Host Research, University College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>St Vincent's University Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Curley</LastName><ForeName>Gerard F</ForeName><Initials>GF</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Critical Care, Royal College of Surgeons in Ireland, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Preston</LastName><ForeName>Roger J S</ForeName><Initials>RJS</Initials><Identifier Source="ORCID">0000-0003-0108-4077</Identifier><AffiliationInfo><Affiliation>Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Children's Research Centre, Our Lady's Children's Hospital Crumlin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rehill</LastName><ForeName>Aisling M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McGonagle</LastName><ForeName>Dennis</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Leeds Institute of Rheumatic and Musculoskeletal Medicine (LIRMM), University of Leeds, Leeds, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute for Health Research (NIHR), Leeds Biomedical Research Centre (BRC), Leeds Teaching Hospitals, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ni Cheallaigh</LastName><ForeName>Cliona</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, St James's Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, School of Medicine, Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baker</LastName><ForeName>Ross I</ForeName><Initials>RI</Initials><AffiliationInfo><Affiliation>Western Australia Centre for Thrombosis and Haemostasis, Perth Blood Institute, Murdoch University, Perth, WA, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Irish-Australian Blood Collaborative (IABC) Network, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Renn&#xe9;</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center Hamburg- Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Thrombosis and Hemostasis (CTH), Johannes Gutenberg University Medical Center, Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ward</LastName><ForeName>Soracha E</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Donnell</LastName><ForeName>James S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Coagulation Centre, St James's Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Children's Research Centre, Our Lady's Children's Hospital Crumlin, Dublin, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Irish-Australian Blood Collaborative (IABC) Network, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Irish COVID-19 Vasculopathy Study (iCVS) investigators</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Thromb Haemost</MedlineTA><NlmUniqueID>101170508</NlmUniqueID><ISSNLinking>1538-7836</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014841">von Willebrand Factor</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Thromb Haemost. 2022 Jan;20(1):267-269. doi: 10.1111/jth.15580</RefSource><PMID Version="1">34731533</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014841" MajorTopicYN="N">von Willebrand Factor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">convalescent COVID-19</Keyword><Keyword MajorTopicYN="N">endothelial cell (EC) activation</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>O'Connell</LastName><ForeName>Niamh</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ryan</LastName><ForeName>Kevin</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kenny</LastName><ForeName>Dermot</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fazavana</LastName><ForeName>Judicael</ForeName><Initials>J</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>8</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>10</Day><Hour>17</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34375505</ArticleId><ArticleId IdType="pmc">PMC8420256</ArticleId><ArticleId IdType="doi">10.1111/jth.15490</ArticleId><ArticleId IdType="pii">S1538-7836(22)02169-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Greenhalgh T., Knight M., A'Court C., Buxton M., Husain L. Management of post&#x2010;acute covid&#x2010;19 in primary care. BMJ. 2020;370:m3026. doi: 10.1136/bmj.m3026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi A., Bernabei R., Landi F. Persistent symptoms in patients after acute COVID&#x2010;19. JAMA. 2020;324(6):603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Fogarty H., Dyer A., et al. Prolonged elevation of D&#x2010;dimer levels in convalescent COVID&#x2010;19 patients is independent of the acute phase response. J Thromb Haemost. 2021;19(4):1064&#x2013;1070. doi: 10.1111/jth.15267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15267</ArticleId><ArticleId IdType="pmc">PMC8013297</ArticleId><ArticleId IdType="pubmed">33587810</ArticleId></ArticleIdList></Reference><Reference><Citation>von Meijenfeldt F.A., Havervall S., Adelmeijer J., et al. Sustained prothrombotic changes in COVID&#x2010;19 patients 4 months after hospital discharge. Blood Adv. 2021;5:756&#x2013;759. doi: 10.1182/bloodadvances.2020003968.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2020003968</ArticleId><ArticleId IdType="pmc">PMC7857699</ArticleId><ArticleId IdType="pubmed">33560386</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M., Verleden S.E., Kuehnel M., et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid&#x2010;19. N Engl J Med. 2020;383:120&#x2013;128. doi: 10.1056/NEJMoa2015432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2015432</ArticleId><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Wichmann D., Sperhake J.&#x2010;.P., L&#xfc;tgehetmann M., et al. Autopsy findings and venous thromboembolism in patients with COVID&#x2010;19: a prospective cohort study. Ann Intern Med. 2020;173:268&#x2013;277. doi: 10.7326/m20-2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/m20-2003</ArticleId><ArticleId IdType="pmc">PMC7240772</ArticleId><ArticleId IdType="pubmed">32374815</ArticleId></ArticleIdList></Reference><Reference><Citation>Rapkiewicz A.V., Mai X., Carsons S.E., et al. Megakaryocytes and platelet&#x2010;fibrin thrombi characterize multi&#x2010;organ thrombosis at autopsy in COVID&#x2010;19: a case series. EClinicalMedicine. 2020;24:100434. doi: 10.1016/j.eclinm.2020.100434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100434</ArticleId><ArticleId IdType="pmc">PMC7316051</ArticleId><ArticleId IdType="pubmed">32766543</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox S.E., Akmatbekov A., Harbert J., et al. Pulmonary and cardiac pathology in African American patients with COVID&#x2010;19: an autopsy series from New Orleans. Lancet Respir Med. 2020;8:681&#x2013;686. doi: 10.1016/S2213-2600(20)30243-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30243-5</ArticleId><ArticleId IdType="pmc">PMC7255143</ArticleId><ArticleId IdType="pubmed">32473124</ArticleId></ArticleIdList></Reference><Reference><Citation>Bussani R., Schneider E., Zentilin L., et al. Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID&#x2010;19 pathology. EBioMedicine. 2020;61:103104. doi: 10.1016/j.ebiom.2020.103104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.103104</ArticleId><ArticleId IdType="pmc">PMC7677597</ArticleId><ArticleId IdType="pubmed">33158808</ArticleId></ArticleIdList></Reference><Reference><Citation>Goshua G., Pine A.B., Meizlish M.L., et al. Endotheliopathy in COVID&#x2010;19&#x2010;associated coagulopathy: evidence from a single&#x2010;centre, cross&#x2010;sectional study. Lancet Haematol. 2020;7:e575&#x2013;e582. doi: 10.1016/s2352-3026(20)30216-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2352-3026(20)30216-7</ArticleId><ArticleId IdType="pmc">PMC7326446</ArticleId><ArticleId IdType="pubmed">32619411</ArticleId></ArticleIdList></Reference><Reference><Citation>Panigada M., Bottino N., Tagliabue P., et al. Hypercoagulability of COVID&#x2010;19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost. 2020;18:1738&#x2013;1742. doi: 10.1111/jth.14850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14850</ArticleId><ArticleId IdType="pmc">PMC9906150</ArticleId><ArticleId IdType="pubmed">32302438</ArticleId></ArticleIdList></Reference><Reference><Citation>Rauch A., Labreuche J., Lassalle F., et al. Coagulation biomarkers are independent predictors of increased oxygen requirements in COVID&#x2010;19. J Thromb Haemost. 2020;18:2942&#x2013;2953. doi: 10.1111/jth.15067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15067</ArticleId><ArticleId IdType="pmc">PMC7461161</ArticleId><ArticleId IdType="pubmed">32881304</ArticleId></ArticleIdList></Reference><Reference><Citation>Turecek P.L., Peck R.C., Rangarajan S., et al. Recombinant ADAMTS13 reduces abnormally up&#x2010;regulated von Willebrand factor in plasma from patients with severe COVID&#x2010;19. Thromb Res. 2021;201:100&#x2013;112. doi: 10.1016/j.thromres.2021.02.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2021.02.012</ArticleId><ArticleId IdType="pmc">PMC7890348</ArticleId><ArticleId IdType="pubmed">33662796</ArticleId></ArticleIdList></Reference><Reference><Citation>Peyvandi F., Artoni A., Novembrino C., et al. Hemostatic alterations in COVID&#x2010;19. Haematologica. 2021;106(5):1472&#x2013;1475.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8094101</ArticleId><ArticleId IdType="pubmed">32855280</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward S.E., Fogarty H., Karampini E., et al. ADAMTS13 regulation of VWF multimer distribution in severe COVID&#x2010;19. J Thromb Haemost. 2021;19(8):1914&#x2013;1921. doi: 10.1111/jth.15409.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15409</ArticleId><ArticleId IdType="pmc">PMC8237059</ArticleId><ArticleId IdType="pubmed">34053187</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward S.E., Curley G.F., Lavin M., et al. Willebrand factor propeptide in severe coronavirus disease 2019 (COVID&#x2010;19): evidence of acute and sustained endothelial cell activation. Br J Haematol. 2021;192(4):714&#x2013;719. doi: 10.1111/bjh.17273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.17273</ArticleId><ArticleId IdType="pubmed">33326604</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Sullivan J.M., Gonagle D.M., Ward S.E., Preston R.J.S., O'Donnell J.S. Endothelial cells orchestrate COVID&#x2010;19 coagulopathy. Lancet Haematol. 2020;7:e553&#x2013;e555. doi: 10.1016/S2352-3026(20)30215-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(20)30215-5</ArticleId><ArticleId IdType="pmc">PMC7326442</ArticleId><ArticleId IdType="pubmed">32619412</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Donnell J.S., Peyvandi F., Martin&#x2010;Loeches I. Pulmonary immuno&#x2010;thrombosis in COVID&#x2010;19 ARDS pathogenesis. Intensive Care Med. 2021;47(8):899&#x2013;902. doi: 10.1007/s00134-021-06419-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-021-06419-w</ArticleId><ArticleId IdType="pmc">PMC8164686</ArticleId><ArticleId IdType="pubmed">34052905</ArticleId></ArticleIdList></Reference><Reference><Citation>Harmon S., Preston R.J.S., Ainle F., et al. Dissociation of activated protein C functions by elimination of protein S cofactor enhancement. J Biol Chem. 2008;283:30531&#x2013;30539. doi: 10.1074/jbc.M802338200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M802338200</ArticleId><ArticleId IdType="pmc">PMC2662146</ArticleId><ArticleId IdType="pubmed">18779332</ArticleId></ArticleIdList></Reference><Reference><Citation>Jim&#xe9;nez&#x2010;Alc&#xe1;zar M., Limacher A., Panda R., et al. Circulating extracellular DNA is an independent predictor of mortality in elderly patients with venous thromboembolism. PLoS One. 2018;13 doi: 10.1371/journal.pone.0191150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0191150</ArticleId><ArticleId IdType="pmc">PMC5825008</ArticleId><ArticleId IdType="pubmed">29474368</ArticleId></ArticleIdList></Reference><Reference><Citation>Jim&#xe9;nez&#x2010;Alc&#xe1;zar M., Rangaswamy C., Panda R., et al. Host DNases prevent vascular occlusion by neutrophil extracellular traps. Science. 2017;358:1202&#x2013;1206. doi: 10.1126/science.aam8897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aam8897</ArticleId><ArticleId IdType="pubmed">29191910</ArticleId></ArticleIdList></Reference><Reference><Citation>Bj&#xf6;rkqvist J., de Maat S., Lewandrowski U., et al. Defective glycosylation of coagulation factor XII underlies hereditary angioedema type III. J Clin Invest. 2015;125:3132&#x2013;3146. doi: 10.1172/JCI77139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI77139</ArticleId><ArticleId IdType="pmc">PMC4563738</ArticleId><ArticleId IdType="pubmed">26193639</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalder T., Berelowitz G., Pawlikowska T., et al. Development of a fatigue scale. J Psychosom Res. 1993;37:147&#x2013;153. doi: 10.1016/0022-3999(93)90081-p.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-3999(93)90081-p</ArticleId><ArticleId IdType="pubmed">8463991</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkins P.V., Rawley O., Smith O.P., O'Donnell J.S. Elevated factor VIII levels and risk of venous thrombosis. Br J Haematol. 2012;157:653&#x2013;663. doi: 10.1111/j.1365-2141.2012.09134.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2141.2012.09134.x</ArticleId><ArticleId IdType="pubmed">22530883</ArticleId></ArticleIdList></Reference><Reference><Citation>Turecek P.L., Johnsen J.M., Pipe S.W., O'Donnell J.S. Biological mechanisms underlying inter&#x2010;individual variation in factor VIII clearance in haemophilia. Haemophilia. 2020;26:575&#x2013;583. doi: 10.1111/hae.14078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/hae.14078</ArticleId><ArticleId IdType="pmc">PMC7496649</ArticleId><ArticleId IdType="pubmed">32596930</ArticleId></ArticleIdList></Reference><Reference><Citation>Gleeson E.M., O'Donnell J.S., Preston R.J. The endothelial cell protein C receptor: cell surface conductor of cytoprotective coagulation factor signaling. Cell Mol Life Sci. 2012;69:717&#x2013;726. doi: 10.1007/s00018-011-0825-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-011-0825-0</ArticleId><ArticleId IdType="pmc">PMC11115159</ArticleId><ArticleId IdType="pubmed">21968919</ArticleId></ArticleIdList></Reference><Reference><Citation>Giri H., Panicker S.R., Cai X., Biswas I., Weiler H., Rezaie A.R. Thrombomodulin is essential for maintaining quiescence in vascular endothelial cells. Proc Natl Acad Sci USA. 2021;118(11)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7980409</ArticleId><ArticleId IdType="pubmed">33836597</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong S.M., Darwish I., Lee W.L. Endothelial activation and dysfunction in the pathogenesis of influenza A virus infection. Virulence. 2013;4:537&#x2013;542. doi: 10.4161/viru.25779.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/viru.25779</ArticleId><ArticleId IdType="pmc">PMC5359731</ArticleId><ArticleId IdType="pubmed">23863601</ArticleId></ArticleIdList></Reference><Reference><Citation>Teijaro J.R., Walsh K.B., Cahalan S., et al. Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell. 2011;146:980&#x2013;991. doi: 10.1016/j.cell.2011.08.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2011.08.015</ArticleId><ArticleId IdType="pmc">PMC3176439</ArticleId><ArticleId IdType="pubmed">21925319</ArticleId></ArticleIdList></Reference><Reference><Citation>Stals M.A.M., Grootenboers M.J.J.H., Guldener C., et al. Risk of thrombotic complications in influenza versus COVID&#x2010;19 hospitalized patients. Res Pract Thromb Haemost. 2021;5:412&#x2013;420. doi: 10.1002/rth2.12496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rth2.12496</ArticleId><ArticleId IdType="pmc">PMC8014477</ArticleId><ArticleId IdType="pubmed">33821230</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>